mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.03 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.03 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.03 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.03 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.03 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
0.03 |